Relevance of stroke subtype in vascular risk prediction

Neurology

Volumn 81, Issue 6, 2013, Pages 575-580

  Ois, Angel ^a   Cuadrado Godia, Elisa ^a   Rodríguez Campello, Ana ^a   Giralt Steinhauer, Eva ^a   Jiménez Conde, Jordi ^a   Lopez Cuiña, Miguel ^a   Ley, Miguel ^a   Soriano, Carol ^a   Roquer, Jaume ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STROKE;

EID: 84884571233     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31829e6f37     Document Type: Article

References (31)

1. Lackland DT, Elkind MS, D'Agostino RS, et al. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012;43:1998-2027.
2. Weimar C, Diener H, Alberts MJ, et al. The Essen stroke risk score predicts recurrent cardiovascular events. Stroke 2009;40:350-354.
3. Weimar C, Benemann J, Michalski D, et al. Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke. Stroke 2010; 41:487-493.
4. Wilson PW, D'Agostino RS, Bhatt DL, et al. An international model to predict recurrent cardiovascular disease. Am J Med 2012;125:695-703.
5. Dhamoon MS, Tai W, Boden-Albala B, et al. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke 2007;38:1752-1758.
6. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
7. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 2005;58: 688-697.
8. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569-573.
9. Purroy F, Montaner J, Molina CA, Delgado P, Ribo M, Álvarez- Sabín J. Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke 2007;38:3225-3229.
10. Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 2010;304:1350-1357.
11. Ohman EM, Bhatt DL, Steg PG, et al. The REduction of atherothrombosis for continued health (REACH) registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J 2006;151:786.e1-786.e10.
12. Ois A, Cuadrado-Godia E, Rodriguez-Campello A, Jimenez-Conde J, Roquer J. High risk of early neurological recurrence in symptomatic carotid stenosis. Stroke 2009;40:2727-2731.
13. Acharjee S, Qin J, Murphy SA, McCabe C, Cannon CP. Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial). Am J Cardiol 2010;105:619-623.
14. Roquer J, Ois A, Rodriguez-Campello A, et al. Atherosclerotic burden and early mortality in acute ischemic stroke. Arch Neurol 2007;64:699-704.
15. Venketasubramanian N, Rother J, Bhatt DL, et al. Twoyear vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registry. Cerebrovasc Dis 2011;32:254-260.
16. Writing Committee Members, Greenland P, Alpert JS, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2010;122:e584-e636.
17. Feng W, Hendry RM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology 2010;74:588-593.
18. Kaplan RC, Tirschwell DL, Longstreth WT, et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology 2005;65:835-842.
19. Kolominsky-Rabas PL,Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and longterm survival in ischemic stroke subtypes: a population-based study. Stroke 2001;32:2735-2740.
20. Mohan KM, Crichton SL, Grieve AP, Rudd AG, Wolfe CDA, Heuschmann PU. Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register. J Neurol Neurosurg Psychiatry 2009;80:1012-1018.
21. Jackson C, Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 2005;128:2507-2517.
22. Shin D, Lee P, Bang O. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. Arch Neurol 2005;62:1232-1237.
23. Hohnloser SH, Oldgren J, Yang S, et al. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial/clinical perspective. Circulation 2012;125:669-676.
24. Melkas S, Putaala J, Oksala NKJ, et al. Small-vessel disease relates to poor poststroke survival in a 12-year follow-up. Neurology 2011;76:734-739.
25. Arboix A, Font A, Garro C, García-Eroles L, Comes E, Massons J. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J Neurol Neurosurg Psychiatry 2007;78:1392-1394.
26. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 2000;31:1062-1068.
27. SPS3 Investigators. Benavente OR, Hart RG, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012;367:817-825.
28. Serena J, Marti-Fàbregas J, Santamarina E, et al. Recurrent stroke and massive right-to-left shunt. Stroke 2008;39: 3131-3136.
29. Sumi S, Origasa H, Houkin K, et al. A modified Essen Stroke Risk score for predicting recurrent cardiovascular events: development and validation. Int J Stroke 2013;8: 251-257.
30. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-189.
31. Ay H, Gungor L, Arsava EM, et al. A score to predict early risk of recurrence after ischemic stroke. Neurology 2010; 74:128-135.